187 related articles for article (PubMed ID: 9680137)
1. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
Ibe M; Sakaguchi T; Tanaka K; Saito S; Yokota S; Tanaka T; Shimotohno K; Chujoh Y; Shiratori Y; Omata M; Miwa K; Takiguchi M
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
[TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
4. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
[TBL] [Abstract][Full Text] [Related]
5. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein.
Kita H; Hiroishi K; Moriyama T; Okamoto H; Kaneko T; Ohnishi S; Yazaki Y; Imawari M
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3189-93. PubMed ID: 8847528
[TBL] [Abstract][Full Text] [Related]
6. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
7. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
[TBL] [Abstract][Full Text] [Related]
8. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
9. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
10. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
Kurokohchi K; Arima K; Nishioka M
J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
Hiroishi K; Kita H; Kojima M; Okamoto H; Moriyama T; Kaneko T; Ishikawa T; Ohnishi S; Aikawa T; Tanaka N; Yazaki Y; Mitamura K; Imawari M
Hepatology; 1997 Mar; 25(3):705-12. PubMed ID: 9049223
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
13. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
14. [Forecasting of hepatitis C virus CTL epitopes and design of multi-epitopes vaccine].
Li D; Xie YW; Xue XP; Bai XF; Jia ZS
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):786-7. PubMed ID: 19874698
[No Abstract] [Full Text] [Related]
15. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
Guo HZ; Wang WL; Wang T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
[TBL] [Abstract][Full Text] [Related]
16. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
[TBL] [Abstract][Full Text] [Related]
17. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Wang Y; Takao Y; Harada M; Yutani S; Ide T; Sata M; Itoh K; Yamada A
Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
Koziel MJ; Walker BD
Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
[TBL] [Abstract][Full Text] [Related]
19. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
Sarobe P; Huarte E; Lasarte JJ; López-Díaz de Cerio A; García N; Borrás-Cuesta F; Prieto J
J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
